Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × INDIV × macimorelin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Cancer Cachexia 1

Interventions

Proflavine 2 Microbial Collagenase 2 pegfilgrastim 1 macimorelin 1 Uracil 1 Tegafur 1 Sirolimus 1 Mifepristone 1 Gemcitabine 1 Everolimus 1 Darbepoetin alfa 1 Corlux 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01614990 2024-03-20

Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia

Garcia, Jose M., MD, PhD

Phase 2 Completed

15 enrolled 35 charts

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡